Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1997 1
2011 1
2014 1
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for indrak vitro
Your search for Indrek Virro retrieved no results
A new alpha-thalassemia-2 deletion resulting in microcytosis and hypochromia and in vitro chain imbalance in the heterozygote.
Indrak K, Gu YC, Novotny J, Huisman TH. Indrak K, et al. Am J Hematol. 1993 Jun;43(2):144-5. doi: 10.1002/ajh.2830430214. Am J Hematol. 1993. PMID: 8342542
Unexpectedly, the heterozygote had a mild anemia with a marked microcytosis and hypochromia, and an in vitro alpha/beta chain synthesis ratio of 0.62-0.66. It is suggested that the deletion includes a sequence that is involved in the in cis regulation of the alpha 2-globin …
Unexpectedly, the heterozygote had a mild anemia with a marked microcytosis and hypochromia, and an in vitro alpha/beta chain synthes …
Flow cytometric monitoring of the in vitro inhibition of the phosphorylation of CRKL and of SRC family kinases in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
Krupkova L, Mojzikova R, Novotny J, Gazdova J, Divoka M, Skoumalova I, Rohon P, Jarosova M, Indrak K, Faber E, Divoky V. Krupkova L, et al. Int J Lab Hematol. 2015 Feb;37(1):e11-5. doi: 10.1111/ijlh.12258. Epub 2014 May 21. Int J Lab Hematol. 2015. PMID: 24845482 No abstract available.
Identification of e6a2 BCR-ABL fusion in a Philadelphia-positive CML with marked basophilia: implications for treatment strategy.
Rohon P, Divoka M, Calabkova L, Mojzikova R, Katrincsakova B, Rusinakova Z, Lapcikova A, Raida L, Faber E, Jarosova M, Divoky V, Indrak K. Rohon P, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Jun;155(2):187-90. doi: 10.5507/bp.2011.030. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011. PMID: 21804629 Free article.
The BCR-ABL mutational status was assessed using sequencing of the RT-PCR products. The in vitro test of sensitivity to TKIs was based on detecting inhibited phosphorylation of the Crkl and Phospho-Src family kinases (SFK, Tyr416) using immunodetection. ...Western blot ana …
The BCR-ABL mutational status was assessed using sequencing of the RT-PCR products. The in vitro test of sensitivity to TKIs was base …
Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias.
Kralovics R, Indrak K, Stopka T, Berman BW, Prchal JF, Prchal JT. Kralovics R, et al. Blood. 1997 Sep 1;90(5):2057-61. Blood. 1997. PMID: 9292543 Free article.
In both cases the EPO dose responses of the erythroid progenitors of the affected subjects were examined to confirm the diagnosis of PFCP. In one of these families, the in vitro behavior of erythroid progenitors in serum-containing cultures without the addition of EPO mimi …
In both cases the EPO dose responses of the erythroid progenitors of the affected subjects were examined to confirm the diagnosis of PFCP. I …